Ajanta Pharma Ltd Share Price (AJANTPHARM)

Ajanta Pharma Among 33 TTC Compounders - 28 Sep, 2023

Ajanta Pharma is one of the 33 stocks that have given 100% returns in the last 20 years and can be termed through-the-cycle (TTC) compounders 100-baggers.

Ajanta Pharma Leads in Sales Growth - 18 Sep, 2023

Ajanta Pharma Ltd emerged as the leader in terms of growth in August with sales growth of 11.6 percent on year.

Ajanta Pharma Hits Record High on Strong Business Outlook - 13 Sep, 2023

Ajanta Pharma's stock rallies 11% to a record high on improved business outlook and strong Q1-FY24 results. The company also outperformed the market with its ophthalmology, pain therapy, and dermatology therapies.

Ajanta Pharma Receives USFDA Approval - 31 Aug, 2023

Ajanta Pharma Ltd has received final approval from the United States Food and Drug Administration (USFDA) to market Topiramate Extended-Release Capsules, 25 mg, 50 mg, 100 mg, and 200mg. The company can launch Topiramate on February 1, 2026 or earlier under certain circumstances.

Ajanta Pharma Receives USFDA Approval for Topiramate Extended-Release Capsules - 30 Aug, 2023

Ajanta Pharma has received final approval from the USFDA to market Topiramate Extended-Release Capsules, a generic version of Trokendi XR™. The drug can be launched on February 1, 2026, or earlier under certain circumstances.

Ajanta Pharma's Debt Management Analyzed - 26 Aug, 2023

An article analyzes Ajanta Pharma Limited's use of debt, focusing on its balance sheet and ability to manage its debt safely.

Ajanta Pharma Preferred by Brokerage Despite Decent US Approval - 24 Aug, 2023

Brokerage reports that Ajanta Pharma has a decent approval in the last few months, supporting their US growth quarter-on-quarter. The brokerage continues to prefer Ajanta Pharma.

Ajanta Pharma Hits New 52-Week High - 17 Aug, 2023

Ajanta Pharma Ltd's stock hits a new 52-week high at Rs 1,804.70 due to the company's focus on pharmaceutical research and development in the healthcare sector.

Ajanta Pharma Hits 52-Week High - 16 Aug, 2023

Ajanta Pharma Ltd's stock hits a new milestone by reaching a 52-week high of Rs 1,804.00.

Ajanta Pharma Registers Growth in Indian Market - 14 Aug, 2023

Ajanta Pharma Ltd has registered growth in the 8-11% YoY range in the Indian pharma market for July.

Ajanta Pharma Hits All-Time Highs - 08 Aug, 2023

Ajanta Pharma's stock is trading at all-time highs, with shares above its IPO price. The stock also exhibits strong buying activity, but investors should watch for potential trend reversals.

Ajanta Pharma Announces Dividend; RSI Indicates Overbought Situation - 04 Aug, 2023

Ajanta Pharma Ltd announces an interim dividend of Rs 10 per equity share and a special dividend of Rs 15. The company's RSI has surpassed 80, indicating a potential overbought situation.

Ajanta Pharma Stock Reaches 52-Week High - 03 Aug, 2023

Ajanta Pharma Ltd's stock reached a 52-week high of Rs 1,776.70.

Ajanta Pharma Q1FY24 Results Show Improvement in Margins - 01 Aug, 2023

Ajanta Pharma's Q1FY24 results show improvement in gross and EBITDA margins due to softening of raw material and freight costs. Management maintains double-digit revenue growth and margin guidance for FY24. ICICI Securities raises earnings estimates by 7%/6% and maintains BUY call with target price of INR 1,870.

Ajanta Pharma Posts In-Line Sales with Better-Than-Expected Profitability - 31 Jul, 2023

Ajanta Pharma's 1QFY24 sales were in line with expectations, but profitability exceeded estimates due to lower raw material and freight costs. Earnings estimates for FY24/FY25 have been raised by 7.5% each, and the stock is rated a BUY with a TP of INR1,800.

Ajanta Pharma Stock Breaks Out Above Previous Swing High - 30 Jul, 2023

Ajanta Pharma Ltd's stock has broken out above its previous swing high and is set to target even higher levels in the coming months, with a potential target of around 2200. The company is also trading ex-dividend with an upcoming dividend of ₹25.00 per share.

Ajanta Pharma Reports Strong Q1FY24 Results - 28 Jul, 2023

Ajanta Pharma Ltd.'s Q1FY24 net profit surged 19.2% YoY to Rs. 208.1 crore, revenue grew 7.4% YoY to Rs. 1021 crore. The company announced a special dividend of Rs. 15 per share and regular dividend of Rs. 10 per share.

Ajanta Pharma Reports Strong Q1 Results and Approves Dividend - 27 Jul, 2023

Ajanta Pharma Ltd reported strong Q1 results with revenue at Rs. 1,021 crore and approved a 1st interim dividend of Rs. 315 cr for FY 2024.

Ajanta Pharma Hits 52-Week High - 25 Jul, 2023

Ajanta Pharma's stock soared to a new high, reaching Rs 1,568.00 due to its strong presence in domestic and international markets.

Ajanta Pharma Board to Consider Interim Dividend and Q1 Results - 24 Jul, 2023

Ajanta Pharma's board of directors will meet on July 27 to consider declaring an interim dividend, if any, for the financial year ending March 31, 2024. The company will also announce its unaudited financial results for the June quarter in the same meeting.